NC MEDICAL RES INC has a total of 20 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), China and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are CHANGCHUN HUAPU BIOTECHNOLOGY CO LTD, CELLECT BIOTHERAPEUTICS LTD and RIBOSTEM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | China | 4 | |
#3 | United States | 4 | |
#4 | Taiwan | 2 | |
#5 | Brazil | 1 | |
#6 | Japan | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | IT methods for management | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Koga Minako | 13 |
#2 | Sasaki Keishin | 10 |
#3 | Chase Thomas N | 9 |
#4 | Honmou Osamu | 6 |
#5 | Uede Teiji | 4 |
#6 | Thomas N Chase | 4 |
#7 | Hashi Kazuo | 4 |
#8 | Hamada Hirofumi | 2 |
#9 | Hashimoto Yasuhiro | 1 |
#10 | Hayashi Nobuhiro | 1 |
Publication | Filing date | Title |
---|---|---|
JP2017145259A | Cell therapy for treatment of neurodegeneration | |
US2014219969A1 | Cell therapy for the treatment of neurodegeneration | |
EP2292735A1 | Cell fractions containing cells capable of differentiating into neural cells |